KIDS - OrthoPediatrics Corp Stock Price, Fair Value and News

30.25USD-0.06 (-0.20%)Delayed as of 22 Apr 2024, 10:48 am ET

Market Summary

USD30.25-0.06

Delayedas of 22 Apr 2024, 10:48 am

-0.20%

KIDS Stock Price

View Fullscreen

KIDS RSI Chart

KIDS Valuation

Market Cap

713.8M

Price/Earnings (Trailing)

-34.03

Price/Sales (Trailing)

4.8

EV/EBITDA

-185.74

Price/Free Cashflow

-16.25

KIDS Price/Sales (Trailing)

KIDS Profitability

Operating Margin

82.99%

EBT Margin

-14.33%

Return on Equity

-5.56%

Return on Assets

-4.78%

Free Cashflow Yield

-6.15%

KIDS Fundamentals

KIDS Revenue

Revenue (TTM)

148.7M

Rev. Growth (Yr)

21.36%

Rev. Growth (Qtr)

-5.9%

KIDS Earnings

Earnings (TTM)

-21.0M

Earnings Growth (Yr)

14.74%

Earnings Growth (Qtr)

-45.74%

Breaking Down KIDS Revenue

52 Week Range

28.1253.50

(Low)(High)

Last 7 days

-2.6%

Last 30 days

9.9%

Last 90 days

5.0%

Trailing 12 Months

-38.7%

KIDS Financial Health

Current Ratio

5.44

Debt/Equity

0.03

Debt/Cashflow

-2.73

KIDS Investor Care

Shares Dilution (1Y)

2.42%

Diluted EPS (TTM)

-0.92

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	130.5M	137.1M	142.1M	148.7M
2022	100.0M	106.2M	116.1M	122.3M
2021	76.2M	89.3M	92.2M	98.0M
2020	74.3M	69.6M	71.1M	71.1M
2019	60.1M	63.2M	68.2M	72.6M
2018	48.0M	51.2M	54.7M	57.6M
2017	39.0M	41.1M	43.4M	45.6M
2016	32.6M	34.2M	35.7M	37.3M
2015	0	0	0	31.0M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of OrthoPediatrics Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 11, 2024	throdahl mark c	sold	-67,126	27.59	-2,433	-
Mar 11, 2024	bailey david r	sold	-88,646	27.59	-3,213	president and ceo
Mar 11, 2024	gerritzen daniel j	sold	-75,624	27.59	-2,741	general counsel and secretary
Mar 11, 2024	hite fred	sold	-88,150	27.59	-3,195	coo and cfo
Mar 11, 2024	odle gregory a	sold	-76,369	27.59	-2,768	president of scoliosis
Feb 22, 2024	hauser joseph w	sold	-81,458	28.06	-2,903	pres. trauma & def. correction
Dec 21, 2023	bailey david r	gifted	-	-	-1,200	president and ceo
Aug 11, 2023	schlotterback terry d	sold	-99,832	38.25	-2,610	-
Aug 07, 2023	schlotterback terry d	acquired	20,749	30.97	670	-
Aug 07, 2023	schlotterback terry d	sold (taxes)	-20,994	39.6865	-529	-

Which funds bought or sold KIDS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 18, 2024	WASATCH ADVISORS LP	added	21.19	1,170,340	14,618,200	0.08%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	-	-	-%
Apr 18, 2024	Park Place Capital Corp	unchanged	-	-757	6,590	-%
Apr 16, 2024	Indiana Trust & Investment Management CO	unchanged	-	-22,663	197,267	0.08%
Apr 16, 2024	MCF Advisors LLC	reduced	-65.73	-12,880	5,716	-%
Apr 09, 2024	MATHER GROUP, LLC.	new	-	1,333	1,333	-%
Apr 09, 2024	MASSMUTUAL TRUST CO FSB/ADV	reduced	-20.00	-322	816	-%
Apr 05, 2024	GAMMA Investing LLC	added	19.11	1,938	7,815	-%
Apr 05, 2024	CWM, LLC	added	0.92	-3,000	29,000	-%
Apr 03, 2024	Versant Capital Management, Inc	sold off	-100	-390	-	-%

Are Funds Buying or Selling KIDS?

Are funds buying KIDS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own KIDS

No. of Funds

Unveiling OrthoPediatrics Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	brown capital management llc	14.21%	3,318,217	SC 13G/A
Feb 09, 2024	brown advisory inc	6.9%	1,621,102	SC 13G/A
Jan 31, 2024	blackrock inc.	5.1%	1,200,135	SC 13G
Feb 14, 2023	brown capital management llc	13.87%	3,175,993	SC 13G/A
Feb 09, 2023	brown advisory inc	6.9%	1,583,702	SC 13G/A
Feb 08, 2023	riverbridge partners llc	4.63%	941,004	SC 13G/A
Sep 22, 2022	squadron capital llc	30.1%	6,901,764	SC 13D/A
Aug 17, 2022	squadron capital llc	30.1%	6,901,764	SC 13D/A
Feb 24, 2022	blackrock inc.	4.7%	937,416	SC 13G/A
Feb 14, 2022	brown capital management llc	13.71%	2,698,315	SC 13G/A

Recent SEC filings of OrthoPediatrics Corp

View All Filings

Date Filed	Form Type	Document
Apr 08, 2024	DEFA14A	DEFA14A
Apr 08, 2024	DEF 14A	DEF 14A
Mar 15, 2024	S-3	S-3
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 11, 2024	8-K	Current Report
Mar 08, 2024	10-K	Annual Report

Peers (Alternatives to OrthoPediatrics Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.2B	40.1B	-3.77%	-2.76%	32.53	4.64	-8.12%	-17.45%
BDX	67.7B	19.5B	-1.53%	-10.57%	53.87	3.47	4.02%	-22.04%
ALGN	22.5B	3.9B	-9.16%	-15.16%	50.45	5.81	3.42%	23.09%
BAX	20.0B	14.8B	-5.62%	-8.72%	7.55	1.35	2.12%	209.17%
MID-CAP
ATR	9.2B	3.5B	-0.49%	17.01%	32.33	2.64	4.97%	18.89%
HSIC	9.1B	12.3B	-5.22%	-14.61%	21.9	0.74	-2.44%	-22.68%
BIO	8.2B	2.7B	-16.90%	-39.13%	-12.81	3.06	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.41%	-25.34%	-47.02	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-2.66%	12.41%	-562.64	9.32	33.86%	89.83%
PDCO	2.3B	6.6B	-4.93%	-3.92%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-14.38%	-20.49%	-1.83	0.39	7.73%	-1066.14%
ANIK	383.7M	166.7M	0.86%	-5.21%	-4.64	2.3	6.67%	-456.34%
ANGO	250.7M	324.0M	11.81%	-29.38%	-1.3	0.77	-3.19%	-337.41%
APYX	45.7M	52.3M	-28.65%	-55.25%	-2.44	0.87	17.61%	19.28%
AEMD	3.8M	3.7M	-10.98%	147.46%	-0.31	1.02	5.77%	8.23%

OrthoPediatrics Corp News

Latest updates

OrthoPediatrics Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-5.9%	37,613,000	39,972,000	39,559,000	31,588,000	30,994,000	34,950,000	32,928,000	23,417,000	24,813,000	25,079,000	26,695,000	21,462,000	18,924,000	22,205,000	13,593,000	16,356,000	18,952,000	20,744,000	18,200,000	14,656,000	14,568,000
Gross Profit	-13.7%	26,714,000	30,953,000	30,025,000	23,561,000	21,224,000	25,889,000	24,981,000	18,566,000	18,081,000	18,554,000	20,443,000	16,325,000	15,118,000	17,639,000	10,061,000	12,213,000	14,450,000	15,895,000	13,619,000	10,655,000	10,514,000
Operating Expenses	-1.9%	34,780,000	35,461,000	35,611,000	32,152,000	29,533,000	32,850,000	28,724,000	24,952,000	23,642,000	22,198,000	23,289,000	22,298,000	27,861,000	20,137,000	17,078,000	16,710,000	17,481,000	17,434,000	15,409,000	13,372,000	12,380,000
S&GA Expenses	-8.4%	12,439,000	13,582,000	13,165,000	12,216,000	10,945,000	11,919,000	12,431,000	9,758,000	9,986,000	9,862,000	10,876,000	8,949,000	9,433,000	9,237,000	5,620,000	7,564,000	8,360,000	8,771,000	7,606,000	6,547,000	6,558,000
R&D Expenses	15.1%	2,747,000	2,387,000	2,792,000	2,270,000	2,034,000	2,206,000	1,747,000	2,027,000	1,608,000	1,302,000	1,325,000	1,308,000	2,050,000	1,077,000	881,000	1,265,000	1,905,000	1,396,000	1,234,000	1,213,000	1,277,000
EBITDA Margin	46.3%	-0.03	-0.05	0.07	0.08	0.06	0.12	-0.04	-0.07	-0.09	-0.26	-0.30	-0.45	-	-	-	-	-	-	-	-	-
Interest Expenses	1542.9%	303,000	-21,000	-294,000	210,000	61,500	-708,000	-1,212,000	-566,000	-396,000	-542,000	-581,000	-728,000	-624,000	-1,010,000	-1,399,000	-379,000	-1,306,000	-1,297,000	-632,000	-303,000	3,977,000
Income Taxes	-125.0%	-212,000	849,000	-401,000	-574,000	-48,000	-4,143,000	-439,000	-317,000	-238,000	-292,000	-286,000	-312,000	-723,000	-	-	-	-	-	-	-	-
Earnings Before Taxes	-84.5%	-6,903,000	-3,742,000	-3,287,000	-7,380,000	-7,896,000	14,396,000	-772,000	-9,417,000	-166,000	-2,489,000	-4,042,000	-10,691,000	-14,736,000	-4,539,000	-9,447,000	-4,945,000	-4,329,000	-2,877,000	-2,459,000	-3,020,000	-
EBT Margin	8.7%	-0.14	-0.16	-0.03	-0.01	-0.03	0.03	-0.12	-0.16	-0.18	-0.35	-0.38	-0.52	-	-	-	-	-	-	-	-	-
Net Income	-45.7%	-6,691,000	-4,591,000	-2,886,000	-6,806,000	-7,848,000	18,539,000	-333,000	-9,100,000	72,000	-2,197,000	-3,756,000	-10,379,000	-14,013,000	-4,539,000	-9,447,000	-4,945,000	-5,429,000	-2,664,000	-2,618,000	-3,020,000	-2,468,000
Net Income Margin	9.4%	-0.14	-0.16	0.01	0.03	0.01	0.08	-0.11	-0.15	-0.17	-0.33	-0.37	-0.50	-	-	-	-	-	-	-	-	-
Free Cashflow	-2.1%	-11,379,000	-11,148,000	-9,996,000	-11,401,000	-2,818,000	-7,147,000	-13,438,000	-8,394,000	-2,870,000	-2,931,000	-10,701,000	-4,664,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	1.5%	439	432	435	426	428	430	331	301	304	304	308	313	320	308	328	174	182	153	151	112	112
Current Assets	0.1%	226	226	223	225	227	225	148	131	134	135	145	152	158	161	180	115	128	109	107	93.00	97.00
Cash Equivalents	191.9%	31.00	11.00	10.00	35.00	9.00	37.00	39.00	19.00	9.00	8.00	12.00	23.00	30.00	90.00	113	54.00	72.00	20.00	22.00	53.00	61.00
Inventory	5.3%	106	101	91.00	85.00	78.00	74.00	67.00	64.00	58.00	55.00	56.00	55.00	53.00	52.00	49.00	44.00	38.00	35.00	33.00	28.00	26.00
Net PPE	2.0%	41.00	40.00	40.00	37.00	34.00	36.00	37.00	31.00	29.00	29.00	28.00	28.00	27.00	24.00	24.00	24.00	21.00	22.00	21.00	17.00	13.00
Goodwill	3.5%	84.00	81.00	83.00	84.00	87.00	88.00	15.00	5.00	72.00	70.00	70.00	68.00	71.00	60.00	68.00	52.00	14.00	11.00	11.00	-	-
Liabilities	6.2%	62.00	58.00	55.00	53.00	49.00	47.00	104	86.00	79.00	82.00	86.00	91.00	86.00	69.00	86.00	35.00	40.00	67.00	63.00	32.00	30.00
Current Liabilities	-13.1%	42.00	48.00	44.00	35.00	31.00	29.00	31.00	34.00	30.00	28.00	30.00	37.00	35.00	26.00	25.00	14.00	14.00	46.00	42.00	11.00	9.00
Long Term Debt	-	10.00	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.00	21.00
LT Debt, Current	-	0.00	-	-	-	0.00	-	-	-	-	-	-	-	0.00	-	-	-	0.00	-	-	0.00	0.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.00	21.00
Shareholder's Equity	0.7%	377	374	380	373	379	383	227	215	225	221	222	222	235	239	242	139	142	86.00	88.00	80.00	82.00
Retained Earnings	-3.5%	-197	-191	-186	-183	-176	-168	-187	-187	-178	-178	-175	-172	-161	-147	-143	-133	-128	-123	-120	-118	-115
Additional Paid-In Capital	0.5%	580	578	575	563	561	559	418	396	395	393	391	390	389	387	386	275	271	210	209	198	197
Shares Outstanding	0.1%	23.00	23.00	23.00	23.00	23.00	21.00	20.00	19.00	19.00	19.00	19.00	19.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	445	-	-	-	472	-	-	-	695	-	-	-	594	-	-	-	349	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	13.0%	-7,543	-8,669	-4,373	-6,461	-3,341	-6,058	-8,170	-4,197	-1,235	-937	-8,976	-1,915	-157	-3,666	-7,751	-6,956	-6,926	-429	-6,943	-3,471	-2,728
Share Based Compensation	12.7%	2,668	2,368	3,456	2,113	1,701	1,682	1,770	1,526	1,672	1,440	1,415	1,316	1,484	1,259	2,495	958	707	733	692	471	286
Cashflow From Investing	85.4%	17,922	9,668	-18,223	32,310	-23,227	-103,919	-528	14,303	2,965	-3,044	-1,725	-5,607	-59,056	-1,288	-3,726	-5,623	-1,529	-1,736	-53,675	-4,982	-459
Cashflow From Financing	62680.0%	9,387	-15.00	-2,035	-36.00	-35.00	108,268	27,774	-33.00	-34.00	42.00	-32.00	30.00	-16.00	-19,679	70,957	-4,530	59,966	455	30,062	536	39,415

KIDS Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net revenue	$ 148,732,000	$ 122,289,000	$ 98,049,000
Cost of revenue	37,479,000	31,629,000	24,646,000
Gross profit	111,253,000	90,660,000	73,403,000
Operating expenses:
Sales and marketing	51,402,000	45,053,000	39,673,000
General and administrative	75,421,000	59,383,000	46,061,000
Legal settlement expenses	0	0	150,000
Trademark impairment	985,000	3,609,000	0
Research and development	10,196,000	8,014,000	5,543,000
Total operating expenses	138,004,000	116,059,000	91,427,000
Operating loss	(26,751,000)	(25,399,000)	(18,024,000)
Other (income) expenses:
Interest (income) expense, net	(198,000)	2,424,000	2,247,000
Fair value adjustment of contingent consideration	(2,980,000)	(25,930,000)	(1,800,000)
Other (income) expense, net	(2,261,000)	1,796,000	(1,083,000)
Total other income	(5,439,000)	(21,710,000)	(636,000)
Loss before income taxes	(21,312,000)	(3,689,000)	(17,388,000)
Provision for income taxes (benefit)	(338,000)	(4,947,000)	(1,128,000)
Net (loss) income	$ (20,974,000)	$ 1,258,000	$ (16,260,000)
Weighted average shares outstanding
Basic (in shares)	22,675,477	20,704,556	19,268,255
Diluted (in shares)	22,675,477	20,947,727	19,268,255
Net (loss) income per share
Basic (in dollars per share)	$ (0.92)	$ 0.06	$ (0.84)
Diluted (in dollars per share)	$ (0.92)	$ 0.06	$ (0.84)

KIDS Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS € in Thousands, $ in Thousands	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Current assets:
Cash and cash equivalents	$ 31,055	$ 8,991
Restricted cash	1,972	1,471
Short term investments	49,251	109,299
Accounts receivable - trade, net of allowances of $1,373 and $1,056, respectively	34,617	24,800
Inventories, net	105,851	78,192
Prepaid expenses and other current assets	3,750	3,966
Total current assets	226,496	226,719
Property and equipment, net	41,048	34,286
Other assets:
Amortizable intangible assets, net	69,275	64,980
Goodwill	83,699	86,821
Other intangible assets	15,287	14,921
Other non-current assets	2,940	0
Total other assets	171,201	166,722
Total assets	438,745	427,727
Current liabilities:
Accounts payable - trade	12,649	11,150
Accrued compensation and benefits	11,325	6,744
Current portion of long-term debt with affiliate	152	144
Current portion of acquisition installment payable	10,149	7,815
Other current liabilities	7,391	5,018
Total current liabilities	41,666	30,871
Long-term liabilities:
Acquisition installment payable, net of current portion	3,551	8,019
Contingent consideration	0	2,980
Deferred income taxes	5,483	5,954
Other long-term liabilities	1,112	492
Total long-term liabilities	20,054	18,208
Total liabilities	61,720	49,079
Commitments and contingencies (Note 15)
Stockholders' equity:
Common stock, $0.00025 par value; 50,000,000 shares authorized; 23,378,408 shares and 22,877,962 shares issued and outstanding as of December 31, 2023 and December 31, 2022	6	6
Additional paid-in capital	580,287	560,810
Accumulated deficit	(197,742)	(176,768)
Accumulated other comprehensive loss	(5,526)	(5,400)
Total stockholders' equity	377,025	378,648
Total liabilities and stockholders' equity	438,745	427,727
Nonrelated Party
Long-term liabilities:
Long-term debt, net of current portion	9,297	0
Long-term debt with affiliate, net of current portion	9,297	0
Related Party
Long-term liabilities:
Long-term debt, net of current portion	611	763
Long-term debt with affiliate, net of current portion	$ 611	$ 763

About OrthoPediatrics Corp

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

CEO	Mr. David R. Bailey
WEBSITE	orthopediatrics.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	203

OrthoPediatrics Corp Frequently Asked Questions

What is the ticker symbol for OrthoPediatrics Corp? What does KIDS stand for in stocks?

KIDS is the stock ticker symbol of OrthoPediatrics Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of OrthoPediatrics Corp (KIDS)?

As of Fri Apr 19 2024, market cap of OrthoPediatrics Corp is 713.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KIDS stock?

You can check KIDS's fair value in chart for subscribers.

What is the fair value of KIDS stock?

You can check KIDS's fair value in chart for subscribers. The fair value of OrthoPediatrics Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of OrthoPediatrics Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for KIDS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is OrthoPediatrics Corp a good stock to buy?

The fair value guage provides a quick view whether KIDS is over valued or under valued. Whether OrthoPediatrics Corp is cheap or expensive depends on the assumptions which impact OrthoPediatrics Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KIDS.

What is OrthoPediatrics Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, KIDS's PE ratio (Price to Earnings) is -34.03 and Price to Sales (PS) ratio is 4.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KIDS PE ratio will change depending on the future growth rate expectations of investors.